Main competitors
Dividend Yield (N) Dividend Yield (N+1) P/E (N) Price to Book (N) EV / Sales (N) EV / EBITDA (N) EV / EBIT (N) Capi.($)
- - - - - - - 102M
0.55%0.61%36.25x22.14x12.94x27.18x28.26x 1,089B
2.01%2.11%28.59x7.26x6.53x18.09x19.65x 643B
2.61%2.75%33.13x13101.05x7.75x15.94x16.46x 465B
2.72%2.78%20.2x7.34x4.86x12.04x13.44x 359B
2.74%2.86%22.65x6.38x5.84x14.57x15.45x 303B
1.93%2.05%22.03x4.96x4.53x12.8x13.62x 267B
3.38%3.3%14.79x6.53x5.48x11.3x13.29x 226B
2.57%2.71%25.81x19.83x6.73x11.86x15.39x 212B
2.45%2.54%-48.4x8.49x5.8x32.01x63.66x 167B
6.82%6.88%12.82x1.64x3.13x7.91x8.94x 144B
3.96%4.04%12.34x5.58x3.35x9.02x9.65x 130B
-.--%-.--%27.96x5.62x8.49x19.12x20.04x 124B
5.36%5.67%11.94x1.27x2.23x7.16x8.15x 109B
3.43%3.61%12.81x4.68x3.02x9.34x9.93x 108B
1.96%2.24%22.69x5.13x7.63x14.47x15.15x 70.35B
3.56%3.64%47.41x1.22x2.82x9.99x29x 56.03B
0.48%1.34%20.33x1.65x1.71x8.12x13.64x 52.65B
0.5%0.56%38.22x5.11x8.63x28.63x29.94x 51.98B
Average 2.61% 2.76% 20.09x 734.21x 5.64x 14.98x 19.09x 240.88B
Weighted average by Cap. 2.18% 2.28% 24.24x 1,340.96x 7.43x 17.74x 20.33x
Other Pharmaceuticals